Vemtoberant

Overview

Vemtoberant is a β 3 -adrenergic receptor inhibitor with a human K i of 8.2 nM, and exhibits 400- to 600-fold selectivity over human β 1 -AR and β 2 -AR . Vemtoberant attenuates β 3 -AR -mediated cardiac inhibition. Vemtoberant can be used for the research of systolic heart failure.

Application

Products | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Cardiovascular Disease | Products > Disease Areas > Hypertension | Products > Signaling Pathways > GPCR/G Protein | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Adrenergic Receptor

Product Information

• Catalog No.: HY-148804
• CAS No.: 2169905-68-2
• Molecular Formula: C29H37N3O8S2
• Molecular Weight: 619.75
• Purity: 98.03%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source